NCT06365112 Endoscopic Acetabulum Surgery
| NCT ID | NCT06365112 |
| Status | Recruiting |
| Phase | EARLY_Phase 1 |
| Sponsor | Tampere University Hospital |
| Condition | Acetabulum Fracture |
| Study Type | INTERVENTIONAL |
| Enrollment | 13 participants |
| Start Date | 2024-04 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 1 is the earliest stage of human testing — safety and dosage are the primary focus. Visits are frequent and medical supervision is intensive. You will be among the first people to receive this treatment.
This trial targets 13 participants in total. It began in 2024-04 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Try to develop an endoscopic surgical technique to treat acetabulum fractures
Eligibility Criteria
Inclusion Criteria: * Acetabulum fracture Exclusion Criteria: * \<18years * Previous lower abdominal operation
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06365112 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acetabulum Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06365112 trial and what does that mean for participants?
Phase 1 trials are the first stage of human testing. The primary goal is to assess safety and determine appropriate dosage levels. Participants are closely monitored. These trials typically involve a small number of volunteers.
Is NCT06365112 currently recruiting?
Yes, NCT06365112 is actively recruiting participants. Contact the research team at piia.suomalainen@pirha.fi for enrollment information.
Where is the NCT06365112 trial being conducted?
This trial is being conducted at Tampere, Finland.
Who is sponsoring the NCT06365112 clinical trial?
NCT06365112 is sponsored by Tampere University Hospital. The trial plans to enroll 13 participants.